Matthew J. Kuhn1, Bryce K. Young1,
1Radiology, University of Illinois at Peoria, Peoria, IL, United States; 2Radiology, Southern Illinois University, Springfield, Ilinois, United States; 3Radiology, Southern Illinois University, Springfield, IL, United States
As part of an ongoing prospective multicenter study to determine the incidence of NSF in patients with stages 3 to 5 chronic kidney disease (CKD) undergoing magnetic resonance imaging (MRI) of the central nervous system with gadobenate dimeglumine, 223 patients have been enrolled at 15 sites. Patients are followed for 2 years with a regular schedule of telephone calls and visits. To date, no case of NSF has been reported, although follow-up is ongoing in most of these patients.